Results of Avastin phase II trial from Genentech slow down aggressive brain cancer in phase II study and could possibly provide brain cancer treatment.
Get the full story...
Avastin, a relatively new type of drug that shrinks cancerous tumors by cutting off their blood supply, can slow the growth of the most common and deadly form of brain cancer, a pilot study conducted at Duke University Medical Center has found.
Read the full story
